Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by
5,000+ Wall Street analysts over the past 3-months

#	Name	Upside %	Analysts bullish %
26	BCYC 26 Bicycle Therapeutics BCYC $480M	232% upside 4 price targets	0
27	27 Zevra Therapeutics ZVRA $411M	232% upside 3 price targets	0
28	28 Taysha Gene Therapies TSHA $791M	231% upside 5 price targets	0
29	29 Biohaven BHVN $1.56B	226% upside 10 price targets	0
30	30 ProQR Therapeutics PRQR $217M	224% upside 3 price targets	0
31	31 Invivyd IVVD $241M	219% upside 3 price targets	0
32	32 Nurix Therapeutics NRIX $655M	217% upside 5 price targets	0
33	33 Olema Pharmaceuticals OLMA $532M	210% upside 3 price targets	0
34	34 Senseonics Holdings SENS $365M	209% upside 3 price targets	0
35	CAN 35 Canaan Creative CAN $380M	209% upside 3 price targets	0
36	36 Semler Scientific SMLR $410M	208% upside 3 price targets	0
37	37 Evolus EOLS $422M	207% upside 3 price targets	0
38	38 Black Diamond Therapeutics BDTX $180M	206% upside 3 price targets	0
39	39 Coya Therapeutics COYA $90.5M	205% upside 4 price targets	0
40	40 Intellia Therapeutics NTLA $1.33B	204% upside 4 price targets	0
41	41 Korro Bio KRRO $285M	198% upside 4 price targets	0
42	42 89bio ETNB $1.2B	197% upside 3 price targets	0
43	43 Edgewise Therapeutics EWTX $1.46B	190% upside 3 price targets	0
44	44 ATAI Life Sciences ATAI $988M	189% upside 3 price targets	0
45	45 Trevi Therapeutics TRVI $972M	188% upside 4 price targets	0
46	46 Wave Life Sciences WVE $1.08B	187% upside 6 price targets	0
47	47 Syndax Pharmaceuticals SNDX $1.27B	185% upside 5 price targets	0
48	ORKA 48 Oruka Therapeutics, Inc. Common Stock ORKA $607M	180% upside 3 price targets	0
49	49 Gossamer Bio GOSS $680M	179% upside 3 price targets	0
50	50 Solid Biosciences SLDB $426M	178% upside 5 price targets	0